You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NKG2D

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer, Triple Negative Breast Cancer, Sarcoma Trial in Johor Bahru (Adoptive Cell Transfer of NKG2DL-targetting

Unknown status
  • Colorectal Cancer
  • +5 more
  • Adoptive Cell Transfer of NKG2DL-targetting Chimeric Antigen Receptor-grafted Gamma Delta T cell
  • Johor Bahru, Johor, Malaysia
    Landmark Medical Centre
Sep 26, 2019

Acute Myeloid Leukemia/Myelodysplastic Syndrome, Multiple Myeloma (MM) Trial in Belgium, United States (NKR-2 cells)

Unknown status
  • Acute Myeloid Leukemia/Myelodysplastic Syndrome
  • Multiple Myeloma (MM)
  • NKR-2 cells
  • Tampa, Florida
  • +4 more
Sep 18, 2019

NSCLC Trial in Worldwide (BMS-986315, Nivolumab, Pemetrexed)

Not yet recruiting
  • NSCLC
  • Boise, Idaho
  • +12 more
Oct 17, 2023

Vitamin D Deficiency Trial in Jakarta Pusat (Cholecalciferol)

Active, not recruiting
  • Vitamin D Deficiency
  • Jakarta Pusat, DKI Jakarta, Indonesia
    Cipto Mangunkusumo National Center General Hospital
Sep 22, 2023

Laparoscopy Trial in Basel (Gastric bypass surgery with 2D 4K laparoscopic imaging, Gastric bypass surgery with 3D HD

Not yet recruiting
  • Laparoscopy
  • Gastric bypass surgery with 2D 4K laparoscopic imaging
  • Gastric bypass surgery with 3D HD laparoscopic imaging
  • Basel, Switzerland
    Clarunis University Center for Gastrointestinal and Liver Diseas
May 30, 2023

Diabetes type2 Trial in Seoul (D745, D759, D150)

Not yet recruiting
  • Diabetes type2
  • D745, D759, D150
  • Seoul, Korea, Republic of
    Catholic Hospital, Seoul
Jun 26, 2023

Alveolar Ridge Preservation Trial in Taoyuan (procedure, drug, other)

Not yet recruiting
  • Alveolar Ridge Preservation
  • Autologous Tooth Root
  • +2 more
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Nov 15, 2023

Liver and Spleen Stiffness Measured by 2D-SWE for Diagnosis of

Recruiting
  • Liver Fibrosis
  • Liver Cirrhosis
  • Diagnostic Test: Transient elastography (TE) and 2D-shear wave elastography (2D-SWE)
  • Zhuhai, Guangdong, China
    The Fifth Affiliated Hospital, Sun Yat-sen University
Nov 19, 2023

CMV-driven NKG2C+NK Cell Expansion in Human

Unknown status
  • Acute Leukemia
  • +2 more
    • Beijing, Beijing, China
      Peking University Institute of Hematology
    Sep 30, 2020

    Liver and Spleen Stiffness Measured by TE and 2D-SWE for

    Recruiting
    • Liver Cirrhosis
    • +2 more
    • Transient elastography (TE) and 2D-shear wave elastography (2D-SWE)
    • Zhuhai, Guangdong, China
      The Fifth Affiliated Hospital, Sun Yat-sen University
    Nov 16, 2023

    Liver and Spleen Stiffness Measured by TE and 2D-SWE for

    Recruiting
    • Liver Cirrhosis
    • +2 more
    • Diagnostic Test: Transient elastography (TE) and 2D-shear wave elastography (2D-SWE)
    • Zhuhai, Guangdong, China
      The Fifth Affiliated Hospital, Sun Yat-sen University
    Nov 19, 2023

    Diabetes Type 2 With Periodontal Disease Trial in Kirikkale (Vitamin D3K2, Saline Solution)

    Completed
    • Diabetes Mellitus Type 2 With Periodontal Disease
    • Vitamin D3K2
    • Saline Solution
    • Kırıkkale, Turkey
      Kirikkale University
    Oct 5, 2023

    Diabetes, Type 2 Trial (dietary supplement, other, drug)

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Vitamin D
    • +2 more
    • (no location specified)
    Oct 6, 2023

    Type II Diabetes Trial (CKD-379, D759+D745+D150)

    Not yet recruiting
    • Type II Diabetes Mellitus
    • (no location specified)
    Jan 30, 2023

    Type 2 Diabetes Trial (behavioral, device, other)

    Not yet recruiting
    • Type 2 Diabetes
    • Acceptance and Commitment Therapy
    • +2 more
    • (no location specified)
    Sep 5, 2023

    Dengue Fever Trial in Dhaka (Arm-2 : 2,00,000 IU Vitamin D3 oral solution , Arm-3: 4,00,000 IU Vitamin D3 oral solution)

    Recruiting
    • Dengue Fever
    • Arm-2 : 2,00,000 IU Vitamin D3 oral solution , Arm-3: 4,00,000 IU Vitamin D3 oral solution
    • Dhaka, Bangladesh
      Bangabandhu Sheikh Mujib Medical University
    Oct 5, 2023

    Type 2 Diabetes, Exercise, Aging Trial (exercise)

    Not yet recruiting
    • Type 2 Diabetes
    • +2 more
    • exercise
    • (no location specified)
    May 11, 2023

    Type 2 Diabetes Trial in San Francisco (Metformin)

    Not yet recruiting
    • Type 2 Diabetes
    • San Francisco, California
      UCSF Madison Clinic for Pediatric Diabetes
    Nov 1, 2023

    HER-2 Positive Advanced Solid Tumors Trial (D3L-001)

    Not yet recruiting
    • HER-2 Positive Advanced Solid Tumors
    • D3L-001
    • (no location specified)
    Jul 20, 2023

    Fat Infiltration of Multifidus Muscle and Lumbar Foraminal

    Not yet recruiting
    • Low Back Pain
    • Degenerative Condition, Neurologic
    • Spine surgery
    • Nice, France
      University Hospital of Nice
    Aug 30, 2023

    Diabetes, Type 2, Dyslipidemia Associated With Type II Diabetes, Statin Adverse Reaction Trial in Tunis (Atorvastatin 40 Mg Oral

    Completed
    • Diabetes Mellitus, Type 2
    • +5 more
    • Atorvastatin 40 Mg Oral Tablet
    • Tunis, Tunisia
      University Hospital La Rabta
    Apr 7, 2023

    Hypertension Trial (CKD-828, D064, D701)

    Not yet recruiting
    • Hypertension
    • CKD-828, D064, D701
    • (no location specified)
    Apr 18, 2023

    Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease Trial in New York (drug, other, dietary supplement,

    Not yet recruiting
    • Insulin Resistance
    • +3 more
    • Insulin human
    • +11 more
    • New York, New York
      Columbia University Irving Medical Center
    Nov 6, 2023

    Central Insulin Resistance, Diabetes, Type 2, PreDiabetes Trial (Human nasal insulin, Placebo)

    Not yet recruiting
    • Central Insulin Resistance
    • +2 more
    • Human nasal insulin
    • Placebo
    • (no location specified)
    May 12, 2023

    SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation Trial (AVTX-801, Placebo)

    Not yet recruiting
    • SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation
    • (no location specified)
    Jan 12, 2023